Ivana Magovcevic-Liebisch - 06 Jan 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
President and CEO, Director
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
3
Filing time
06 Jan 2022, 19:34:47 UTC
Previous filing
02 Dec 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VIGL Common Stock 198,687 06 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VIGL Stock Option Grant (Right to Buy) 06 Jan 2022 Common Stock 369,351 $1.89 Direct F1
holding VIGL Stock Option Grant (Right to Buy) 06 Jan 2022 Common Stock 210,629 $1.89 Direct F2
holding VIGL Stock Option Grant (Right to Buy) 06 Jan 2022 Common Stock 405,494 $6.02 Direct F3
holding VIGL Stock Option Grant (Right to Buy) 06 Jan 2022 Common Stock 43,271 $9.57 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option vested and became exercisable on July 10, 2021, with the remainder vesting in 36 equal monthly installments thereafter.
F2 The shares subject to this option vest and become exercisable in 48 equal monthly installments, with the first installment vested May 28, 2021.
F3 The shares subject to this option vest and become exercisable in 48 equal monthly installments, with the first installment vested September 13, 2021.
F4 The shares subject to this option vest and become exercisable in 48 equal monthly installments, with the first installment vested November 14, 2021.

Remarks:

Exhibit 24 - Power of Attorney